196 related articles for article (PubMed ID: 9557614)
1. Characterization of the chimeric retinoic acid receptor RARalpha/VDR.
Pemrick SM; Abarzúa P; Kratzeisen C; Marks MS; Medin JA; Ozato K; Grippo JF
Leukemia; 1998 Apr; 12(4):554-62. PubMed ID: 9557614
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
[TBL] [Abstract][Full Text] [Related]
3. AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor.
Puccetti E; Obradovic D; Beissert T; Bianchini A; Washburn B; Chiaradonna F; Boehrer S; Hoelzer D; Ottmann OG; Pelicci PG; Nervi C; Ruthardt M
Cancer Res; 2002 Dec; 62(23):7050-8. PubMed ID: 12460926
[TBL] [Abstract][Full Text] [Related]
4. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
5. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
Dong S; Tweardy DJ
Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.
Thummel KE; Brimer C; Yasuda K; Thottassery J; Senn T; Lin Y; Ishizuka H; Kharasch E; Schuetz J; Schuetz E
Mol Pharmacol; 2001 Dec; 60(6):1399-406. PubMed ID: 11723248
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-beta2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression.
Jiménez-Lara AM; Aranda A
Endocrinology; 1999 Jun; 140(6):2898-907. PubMed ID: 10342883
[TBL] [Abstract][Full Text] [Related]
8. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA.
Kahlen JP; Carlberg C
Nucleic Acids Res; 1997 Nov; 25(21):4307-13. PubMed ID: 9336462
[TBL] [Abstract][Full Text] [Related]
9. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
Matkovits T; Christakos S
Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
[TBL] [Abstract][Full Text] [Related]
10. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo.
Lemon BD; Freedman LP
Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
Fernandez-Martin JL; Kurian S; Farmer P; Nanes MS
Mol Cell Endocrinol; 1998 Jun; 141(1-2):65-72. PubMed ID: 9723887
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of transcriptional activity of oestrogen receptors by direct protein-protein interactions with retinoid receptors.
Song MR; Lee SK; Seo YW; Choi HS; Lee JW; Lee MO
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):711-7. PubMed ID: 9841885
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
Liu YY; Nguyen C; Peleg S
Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811
[TBL] [Abstract][Full Text] [Related]
15. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo.
Li XY; Xiao JH; Feng X; Qin L; Voorhees JJ
J Invest Dermatol; 1997 Apr; 108(4):506-12. PubMed ID: 9077482
[TBL] [Abstract][Full Text] [Related]
16. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
[TBL] [Abstract][Full Text] [Related]
17. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
Tagami T; Lutz WH; Kumar R; Jameson JL
Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
[TBL] [Abstract][Full Text] [Related]
18. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
[TBL] [Abstract][Full Text] [Related]
19. Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators).
Le Douarin B; vom Baur E; Zechel C; Heery D; Heine M; Vivat V; Gronemeyer H; Losson R; Chambon P
Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):569-78. PubMed ID: 8735280
[TBL] [Abstract][Full Text] [Related]
20. L7 protein is a coregulator of vitamin D receptor-retinoid X receptor-mediated transactivation.
Berghöfer-Hochheimer Y; Zurek C; Wölfl S; Hemmerich P; Munder T
J Cell Biochem; 1998 Apr; 69(1):1-12. PubMed ID: 9513041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]